Livzon Pharmaceutical Group Inc. (HKG: 1513)

Livzon Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Jan 1, 2021	Jan 1, 2020
Market Capitalization	33,015	31,168	31,039	39,657	39,381	30,952
Market Cap Growth	13.19%	0.42%	-21.73%	0.70%	27.23%	61.69%
Enterprise Value	26,637	25,008	25,207	33,283	32,171	24,065
Last Close Price	26.55	22.78	23.19	23.71	24.05	18.63
PE Ratio	-	9.84	10.06	10.18	11.07	11.97
PS Ratio	2.78	2.28	2.17	2.68	3.15	2.95
PB Ratio	2.21	1.92	1.84	2.26	2.43	2.25
P/TBV Ratio	2.42	2.10	2.08	2.56	2.82	2.55
P/FCF Ratio	12.34	11.65	14.98	54.46	21.90	20.20
P/OCF Ratio	9.87	8.71	9.90	16.98	15.34	15.65
EV/Sales Ratio	2.09	1.83	1.77	2.25	2.57	2.29
EV/EBITDA Ratio	7.46	8.31	8.70	11.58	11.19	12.23
EV/EBIT Ratio	10.53	11.81	11.54	14.14	13.35	15.65
EV/FCF Ratio	9.00	9.35	12.17	45.71	17.89	15.70
Debt / Equity Ratio	0.27	0.28	0.24	0.19	0.14	0.11
Debt / EBITDA Ratio	1.23	1.50	1.40	1.14	0.80	0.77
Debt / FCF Ratio	1.53	1.71	1.97	4.54	1.27	0.99
Asset Turnover	0.48	0.50	0.53	0.56	0.55	0.53
Inventory Turnover	2.13	2.32	2.47	2.74	2.82	3.01
Quick Ratio	1.58	1.86	1.97	1.83	2.13	2.16
Current Ratio	1.84	2.14	2.30	2.12	2.40	2.43
Return on Equity (ROE)	15.09%	12.78%	13.37%	13.97%	16.45%	12.17%
Return on Assets (ROA)	5.91%	4.81%	5.11%	5.58%	6.58%	4.85%
Return on Capital (ROIC)	7.84%	6.41%	6.79%	7.36%	8.69%	6.39%
Earnings Yield	6.14%	6.91%	6.95%	5.50%	5.17%	4.71%
FCF Yield	8.10%	8.58%	6.67%	1.84%	4.57%	4.95%
Dividend Yield	5.06%	6.53%	7.80%	6.73%	6.17%	6.91%
Payout Ratio	67.66%	81.36%	83.33%	70.81%	64.15%	66.66%
Buyback Yield / Dilution	0.74%	0.56%	0.04%	0.25%	-0.41%	-0.20%
Total Shareholder Return	0.74%	7.09%	7.84%	6.98%	5.77%	6.71%

Source: S&P Capital IQ. Standard template. Financial Sources.